Perineural Therapy Market Size & Share, by Internal Neurostimulation Devices (Spinal Cord, Vagus Nerve, Deep Brain, Gastric Electrical, Sacral Nerve); Biomaterials (Nerve Conduits, Nerve Wraps); External Neurostimulation Devices (RES, TMS, TENs); End-user (Clinics, Hospitals, Ambulatory Surgical Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

Request Free Sample Copy

Report ID: 4161
Published Date: Mar 20, 2023
Report Format: PDF, PPT

Buy Now

Companies Dominating the Perineural Therapy Landscape

Boston Scientific Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
tVNS Technologies GmbH
Abbott Laboratories
NeuroSigma, Inc.
Axogen Corporation
BioWave Limited
Baxter Healthcare Corporation
LivaNova, PLC
Integra LifeSciences Corporation
Soterix Medical, Inc.

Browse Key Market Insights with Data Illustration:

Perineural Therapy Market Size, Forecast 2023-2035

In the News

Abbott Laboratories to enter an agreement with the FDA regarding the reopening of the company’s Mich., Sturgis, and infant formula plants. As per the agreement, Abbott will continue to import formula from an FDA-registered facility in Ireland.
NeuroSigma, Inc. To enter into a strategic digital health partnership with KT to develop and promote the sales of neuroelectric ADHD within and outside of Korean borders.

Frequently Asked Questions (FAQ)

The higher prevalence of different sorts of neural disorders and the increment in approval of more enhanced products to repair and regenerate nerves are the major factors driving the growth of the perineural therapy market.

The market is anticipated to attain a CAGR of 15% over the forecast period, i.e., 2023-2035.

The lack of skilled medical professionals, the possibilities of side effects such as skin allergy and infection, and the presence of alternatives owing to the lack of awareness are estimated to hamper the market growth.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Boston Scientific Corporation, tVNS Technologies GmbH, Abbott Laboratories, NeuroSigma, Inc., Axogen Corporation., BioWave Limited, Baxter Healthcare Corporation, and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.

The market is segmented by internal neurostimulation devices, biomaterials, external neurostimulation devices, end-user, and by regions.

The nerve conduits sub-segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Companies Dominating the Perineural Therapy Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the perineural therapy market?

What would be the CAGR of perineural therapy market over the forecast period?

What are the challenges affecting the perineural therapy market growth?

Which region will provide more business opportunities for growth of perineural therapy market in future?

Who are the major players dominating the perineural therapy market?

How are the company profiles selected?

What are the segments in the perineural therapy market?

Which segment captures the largest market size in the biomaterials segment in the perineural therapy market?